ARDENT HEALTH PARTNERS INC (ARDT) Stock Fundamental Analysis
NYSE:ARDT - New York Stock Exchange, Inc. - US03980N1072 - Common Stock - Currency: USD
We assign a fundamental rating of 5 out of 10 to ARDT. ARDT was compared to 102 industry peers in the Health Care Providers & Services industry. ARDT has an average financial health and profitability rating. ARDT scores decently on growth, while it is valued quite cheap. This could make an interesting combination.
1. Profitability
1.1 Basic Checks
ARDT had positive earnings in the past year.
In the past year ARDT had a positive cash flow from operations.
1.2 Ratios
Looking at the Return On Assets, with a value of 4.24%, ARDT is in the better half of the industry, outperforming 75.49% of the companies in the same industry.
ARDT has a Return On Equity of 18.59%. This is amongst the best in the industry. ARDT outperforms 86.27% of its industry peers.
ARDT's Return On Invested Capital of 8.48% is fine compared to the rest of the industry. ARDT outperforms 75.49% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ARDT is below the industry average of 9.53%.
The 3 year average ROIC (5.96%) for ARDT is below the current ROIC(8.48%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.24% | ||
| ROE | 18.59% | ||
| ROIC | 8.48% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 3.53%, ARDT is in the better half of the industry, outperforming 69.61% of the companies in the same industry.
ARDT's Profit Margin has improved in the last couple of years.
ARDT's Operating Margin of 6.80% is fine compared to the rest of the industry. ARDT outperforms 72.55% of its industry peers.
In the last couple of years the Operating Margin of ARDT has grown nicely.
ARDT has a better Gross Margin (57.51%) than 79.41% of its industry peers.
ARDT's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.8% | ||
| PM (TTM) | 3.53% | ||
| GM | 57.51% |
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
2. Health
2.1 Basic Checks
ARDT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for ARDT has been increased compared to 1 year ago.
ARDT has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.13 indicates that ARDT is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.13, ARDT is in line with its industry, outperforming 50.98% of the companies in the same industry.
The Debt to FCF ratio of ARDT is 8.59, which is on the high side as it means it would take ARDT, 8.59 years of fcf income to pay off all of its debts.
ARDT has a Debt to FCF ratio (8.59) which is in line with its industry peers.
A Debt/Equity ratio of 0.96 indicates that ARDT is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.96, ARDT is not doing good in the industry: 63.73% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 8.59 | ||
| Altman-Z | 2.13 |
ROIC/WACC1.07
WACC7.92%
2.3 Liquidity
ARDT has a Current Ratio of 1.94. This is a normal value and indicates that ARDT is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ARDT (1.94) is better than 72.55% of its industry peers.
A Quick Ratio of 1.82 indicates that ARDT should not have too much problems paying its short term obligations.
ARDT has a Quick ratio of 1.82. This is in the better half of the industry: ARDT outperforms 71.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.82 |
3. Growth
3.1 Past
ARDT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 314.38%, which is quite impressive.
ARDT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 13.75% yearly.
ARDT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.29%.
The Revenue has been growing slightly by 7.00% on average over the past years.
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
Based on estimates for the next years, ARDT will show a very strong growth in Earnings Per Share. The EPS will grow by 21.97% on average per year.
The Revenue is expected to grow by 6.43% on average over the next years.
EPS Next Y58.43%
EPS Next 2Y28.98%
EPS Next 3Y21.97%
EPS Next 5YN/A
Revenue Next Year8.29%
Revenue Next 2Y6.9%
Revenue Next 3Y6.43%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 9.96, the valuation of ARDT can be described as reasonable.
Based on the Price/Earnings ratio, ARDT is valued cheaper than 91.18% of the companies in the same industry.
ARDT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.03.
With a Price/Forward Earnings ratio of 7.67, the valuation of ARDT can be described as very cheap.
ARDT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ARDT is cheaper than 95.10% of the companies in the same industry.
ARDT's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.94.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.96 | ||
| Fwd PE | 7.67 |
4.2 Price Multiples
93.14% of the companies in the same industry are more expensive than ARDT, based on the Enterprise Value to EBITDA ratio.
74.51% of the companies in the same industry are more expensive than ARDT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.72 | ||
| EV/EBITDA | 4.89 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ARDT has a very decent profitability rating, which may justify a higher PE ratio.
ARDT's earnings are expected to grow with 21.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.17
PEG (5Y)N/A
EPS Next 2Y28.98%
EPS Next 3Y21.97%
5. Dividend
5.1 Amount
ARDT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
14.94
-0.19 (-1.26%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners72.28%
Inst Owner Change0.98%
Ins Owners1.82%
Ins Owner Change1.41%
Market Cap2.13B
Analysts81.25
Price Target20.51 (37.28%)
Short Float %1.5%
Short Ratio3.66
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)15.96%
Min EPS beat(2)-44.28%
Max EPS beat(2)76.2%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2%
Min Revenue beat(2)-2.11%
Max Revenue beat(2)6.1%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.73%
PT rev (3m)-7.75%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-47.76%
EPS NY rev (1m)0.92%
EPS NY rev (3m)-1.36%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.67%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)0.48%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.96 | ||
| Fwd PE | 7.67 | ||
| P/S | 0.36 | ||
| P/FCF | 16.72 | ||
| P/OCF | 6.77 | ||
| P/B | 1.89 | ||
| P/tB | 10.54 | ||
| EV/EBITDA | 4.89 |
EPS(TTM)1.5
EY10.04%
EPS(NY)1.95
Fwd EY13.04%
FCF(TTM)0.89
FCFY5.98%
OCF(TTM)2.21
OCFY14.77%
SpS41.79
BVpS7.93
TBVpS1.42
PEG (NY)0.17
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.24% | ||
| ROE | 18.59% | ||
| ROCE | 10.12% | ||
| ROIC | 8.48% | ||
| ROICexc | 9.85% | ||
| ROICexgc | 13.47% | ||
| OM | 6.8% | ||
| PM (TTM) | 3.53% | ||
| GM | 57.51% | ||
| FCFM | 2.14% |
ROA(3y)3.2%
ROA(5y)N/A
ROE(3y)18.73%
ROE(5y)N/A
ROIC(3y)5.96%
ROIC(5y)N/A
ROICexc(3y)6.85%
ROICexc(5y)N/A
ROICexgc(3y)9.47%
ROICexgc(5y)N/A
ROCE(3y)7.12%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y3%
OM growth 5YN/A
PM growth 3Y3.64%
PM growth 5YN/A
GM growth 3Y2.83%
GM growth 5YN/A
F-Score8
Asset Turnover1.2
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 8.59 | ||
| Debt/EBITDA | 1.97 | ||
| Cap/Depr | 128.18% | ||
| Cap/Sales | 3.14% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 57.06% | ||
| Profit Quality | 60.62% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.82 | ||
| Altman-Z | 2.13 |
F-Score8
WACC7.92%
ROIC/WACC1.07
Cap/Depr(3y)111.7%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.88%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)314.38%
EPS 3Y13.75%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y58.43%
EPS Next 2Y28.98%
EPS Next 3Y21.97%
EPS Next 5YN/A
Revenue 1Y (TTM)10.29%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year8.29%
Revenue Next 2Y6.9%
Revenue Next 3Y6.43%
Revenue Next 5YN/A
EBIT growth 1Y87.99%
EBIT growth 3Y10.2%
EBIT growth 5YN/A
EBIT Next Year71.2%
EBIT Next 3Y26.88%
EBIT Next 5YN/A
FCF growth 1Y51.28%
FCF growth 3Y152.66%
FCF growth 5YN/A
OCF growth 1Y42.1%
OCF growth 3Y28.95%
OCF growth 5YN/A